Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glial Cell-Mediated Neuroinflammation in Alzheimer’s Disease
Nour F. Al-Ghraiybah, Junwei Wang, Amer E. Alkhalifa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10572-10572
Open Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

The Potential Benefits of Quercetin for Brain Health: A Review of Anti-Inflammatory and Neuroprotective Mechanisms
Ming‐Chang Chiang, Tsung‐Yu Tsai, Chieh-Ju Wang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6328-6328
Open Access | Times Cited: 84
Blood–Brain Barrier Breakdown in Alzheimer’s Disease: Mechanisms and Targeted Strategies
Amer E. Alkhalifa, Nour F. Al-Ghraiybah, Julia Odum, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16288-16288
Open Access | Times Cited: 60
Mechanisms of ferroptosis in Alzheimer's disease and therapeutic effects of natural plant products: A review
Zhao Da, Kailin Yang, Hua Guo, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114312-114312
Open Access | Times Cited: 47
Fecal microbiota transplantation attenuates Alzheimer’s disease symptoms in APP/PS1 transgenic mice via inhibition of the TLR4-MyD88-NF-κB signaling pathway-mediated inflammation
Xiang Li, Qingyong Ding, Xinxin Wan, et al.
Behavioral and Brain Functions (2025) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Stress, depression, and risk of dementia – a cohort study in the total population between 18 and 65 years old in Region Stockholm
Johanna Wallensten, Gunnar Ljunggren, Anna Nager, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 33
Recent advancement in bioeffect, metabolism, stability, and delivery systems of apigenin, a natural flavonoid compound: challenges and perspectives
Peng Chen, Fuchao Chen, Zhilei Guo, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 27
Anti-inflammatory role of gold nanoparticles in the prevention and treatment of Alzheimer's disease
Munire Aili, Kebing Zhou, Jun Zhan, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 36, pp. 8605-8621
Open Access | Times Cited: 26
New Pathways Identify Novel Drug Targets for the Prevention and Treatment of Alzheimer’s Disease
Botond Penke, Mária Szűcs, Ferenc Bogár
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5383-5383
Open Access | Times Cited: 23
Extra-Virgin Olive Oil in Alzheimer’s Disease: A Comprehensive Review of Cellular, Animal, and Clinical Studies
Amer E. Alkhalifa, Nour F. Al-Ghraiybah, Amal Kaddoumi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1914-1914
Open Access | Times Cited: 15
Oxidative stress–mediated neuroinflammation in Alzheimer’s disease
Sayed Mohammed Firdous, Sahabaj Ali Khan, Amritangshu Maity
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 14
Kai-Xin-San ameliorates Alzheimer's disease-related neuropathology and cognitive impairment in APP/PS1 mice via the mitochondrial autophagy-NLRP3 inflammasome pathway
Xiaoxiao Shan, Wenwen Tao, Junying Li, et al.
Journal of Ethnopharmacology (2024) Vol. 329, pp. 118145-118145
Closed Access | Times Cited: 11
Disease-Modifying Treatments and Their Future in Alzheimer’s Disease Management
Blake Smith, Raymond L. Ownby
Cureus (2024)
Open Access | Times Cited: 10
A review on traditional Chinese medicine natural products and acupuncture intervention for Alzheimer’s disease based on the neuroinflammatory
Zhihan Chen, Xinrui Wang, Simin Du, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 8
Sleep deprivation: A risk factor for the pathogenesis and progression of Alzheimer's disease
Zhengyun Han, Xingmao Yang, Shuiqing Huang
Heliyon (2024) Vol. 10, Iss. 7, pp. e28819-e28819
Open Access | Times Cited: 8
The neuroinflammatory role of microglia in Alzheimer's disease and their associated therapeutic targets
Melika Amelimojarad, Mandana AmeliMojarad
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 7
Open Access | Times Cited: 8
Curcumin: A Golden Approach to Healthy Aging: A Systematic Review of the Evidence
Yandra Cervelim Nunes, Nathalia. M. Mendes, Enzo Pereira de Lima, et al.
Nutrients (2024) Vol. 16, Iss. 16, pp. 2721-2721
Open Access | Times Cited: 8
Exploring the Role of GLP-1 Receptor Agonists in Alzheimer’s Disease: A Review of Preclinical and Clinical Evidence
Lívia Cristina Ribeiro Teixeira, Marcelo R. Luizon, Karina Braga Gomes
Receptors (2025) Vol. 4, Iss. 1, pp. 2-2
Open Access | Times Cited: 1
Polysaccharides from Astragalus membranaceus Bunge alleviate LPS-induced neuroinflammation in mice by modulating microbe-metabolite-brain axis and MAPK/NF-κB signaling pathway
Dongyuan Liu, Yuying Zhu, Zhenshan Hou, et al.
International Journal of Biological Macromolecules (2025), pp. 140885-140885
Closed Access | Times Cited: 1
Ginsenoside Ro ameliorates cognitive impairment and neuroinflammation in APP/PS1 mice via the IBA1/GFAP-MAPK signaling pathway
Tianyao Li, Jiaxin Chen, Zhouyuan Xie, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access | Times Cited: 1
Mitochondrial DNA and Inflammation in Alzheimer’s Disease
Giacoma Galizzi, Marta Di Carlo
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 11, pp. 8586-8606
Open Access | Times Cited: 18
Anti-Neuroinflammatory Potential of Natural Products in the Treatment of Alzheimer’s Disease
Mingzhenlong Deng, Wanli Yan, Zhicheng Gu, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1486-1486
Open Access | Times Cited: 17
SOCS modulates JAK-STAT pathway as a novel target to mediate the occurrence of neuroinflammation: Molecular details and treatment options
Min Yan, Zhiyuan Sun, Sen Zhang, et al.
Brain Research Bulletin (2024) Vol. 213, pp. 110988-110988
Open Access | Times Cited: 6
Interleukin-6 deficiency reduces neuroinflammation by inhibiting the STAT3-cGAS-STING pathway in Alzheimer’s disease mice
Min Liu, Jirong Pan, Xiaomeng Li, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Peripheral Blood and Cerebrospinal Fluid Levels of YKL-40 in Alzheimer’s Disease: A Systematic Review and Meta-Analysis
Yuchen Zhang, Jinzhou Tian, Jingnian Ni, et al.
Brain Sciences (2023) Vol. 13, Iss. 10, pp. 1364-1364
Open Access | Times Cited: 14
Human Glial Cells as Innovative Targets for the Therapy of Central Nervous System Pathologies
Giulia Magni, Benedetta Riboldi, Stefania Ceruti
Cells (2024) Vol. 13, Iss. 7, pp. 606-606
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top